c-LEcta: Successful Transformation into a Product Company in 2018 with a Promising Outlook for 2019


Dec 13, 2018--c-LEcta, a globally active biotechnology company with technology leadership in enzyme engineering and bioprocess development for regulated markets such as the food and pharmaceutical industries, continued its successful development towards becoming a product company in fiscal year 2018. Successful products marketed by c-LEcta itself such as DENARASEA contributed to this development.



from Biotech News